Ocular Therapeutix (OCUL) Net Margin (2014 - 2026)
Ocular Therapeutix (OCUL) posted Net Margin of -584.51% for Q2 2026, down 80.66 percentage points from -503.86% a year earlier but up 237.11 percentage points from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Net Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Ocular Therapeutix was -579.10%, down 196.59 percentage points year-over-year; for FY2025, it was -511.90%, down 208.24 percentage points from FY2024.
- Annual Net Margin has declined for four consecutive years, though with a five-year change of +382.40 percentage points (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Net Margin was -303.67% in FY2024 (-165.52 pp), -138.14% in FY2023 (-0.19 pp), -137.95% in FY2022 (-122.90 pp) and -15.06% in FY2021 (+879.25 pp).
- Quarterly Net Margin has run from a low of -821.62% in Q1 2026 to a high of 21.86% in Q3 2021 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last 11 quarters, with an average year-over-year change of -183.17 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2021, with a gain of 1133.67 percentage points; the weakest was Q3 2025, with a drop of 240.71 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -821.62% (Q1 2026), -487.95% (Q4 2025) and -477.30% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 32.99% |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | -584.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -584.51% |
| Mar 31, 2026 | -821.62% |
| Dec 31, 2025 | -487.95% |
| Sep 30, 2025 | -477.30% |
| Jun 30, 2025 | -503.86% |
| Mar 31, 2025 | -598.74% |
| Dec 31, 2024 | -283.27% |
| Sep 30, 2024 | -236.58% |
| Jun 30, 2024 | -266.27% |
| Mar 31, 2024 | -438.93% |
| Dec 31, 2023 | -197.42% |
| Sep 30, 2023 | -3.42% |
| Jun 30, 2023 | -136.19% |
| Mar 31, 2023 | -226.69% |
| Dec 31, 2022 | -110.42% |
| Sep 30, 2022 | -202.16% |
| Jun 30, 2022 | -152.99% |
| Mar 31, 2022 | -95.11% |
| Dec 31, 2021 | -31.28% |
| Sep 30, 2021 | 21.86% |
API Access
Ocular Therapeutix Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();